CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. Strassheimer F, Elleringmann P, Ludmirski G, Roller B, et al. Br J Cancer 2025 Mar 18. doi: 10.1038/s41416-025-02977.

Read + Share

Amedeo Smart

Independent Medical Education

Strassheimer F, Elleringmann P, Ludmirski G, Roller B, et al. CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. Br J Cancer 2025 Mar 18. doi: 10.1038/s41416-025-02977.
PMID: 40102596